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lipoproteins (VLDLs) from the liver is vital formaintain-
ing plasma lipid homeostasis. However, the process
of VLDL assembly and lipidation is not well character-
ized. Here, we observed that liver of Cideb null mice
had higher levels of triacylglycerols accompanied
by low level of VLDL secretion. Furthermore, VLDL
particles secreted from hepatocytes of Cideb null
mice have low levels of triacylglycerols but normal
levels of apoB. We also observed that Cideb is local-
ized to endoplasmic reticulum and lipid droplets.
Importantly,wehave identifiedapoBas aCideb-inter-
acting protein. By infecting adenoviruses expressing
various Cideb truncations into hepatocytes of Cideb
null mice, we found that Cideb requires both its
apoB-binding and lipid droplet association domains
to restore the secretion of triacylglycerol-enriched
VLDLparticles.Ourdatasuggest thatCidebpromotes
the formation of triacylglycerol-enriched VLDL parti-
cles andprovides amolecular insight into VLDL lipida-
tion and maturation in hepatocytes.
INTRODUCTION
Increased plasma levels of triacylglycerols (TGs) and cholesterol
are associated with the development of metabolic diseases such
as obesity, insulin resistance, and atherosclerosis. Mature very-
low-density lipoprotein (VLDL) particles secreted from hepato-
cytes contain a hydrophobic core of TG and cholesterol esters
(CEs) and an apolipoprotein (apo) B molecule. Secretion of
VLDL plays a very important role in controlling plasma levels of
TG and cholesterol. VLDL assembly and maturation in hepato-
cytes are generally believed to include two lipidation steps
(reviewed by Olofsson et al., 2000). The first step involves the
addition of small amounts of lipids to apoB-100 while it is trans-
lated and translocated across the endoplasmic reticulum (ER)
membranes to form a partially lipidated, small pre-VLDL particle
in the high density lipoprotein (HDL) density range (Fisher andCelGinsberg, 2002). In the second lipidation step, VLDL precursors
are combined with TG-rich lipid droplets (LDs) to form mature
and secretion-competent VLDL particles. Microsomal triglyc-
eride transfer protein (MTP), an ER-resident protein, plays an
important role in the first step of VLDL lipidation during apoB-
100 translation, as well as accumulation of neutral lipids within
the ER lumen (Gordon, 1997; Raabe et al., 1999).
A long-standing question in VLDL maturation is how and
where neutral lipids from LDs are acquired by VLDL precursor
to form mature VLDL particles. Some investigators concluded
that VLDL particles are completely assembled within ER, in
particular in smooth ER, the site of TG synthesis (reviewed by
Gibbons et al., 2004), whereas others suggested that final lipida-
tion of VLDL occurs in post-ER or the Golgi apparatus (Gusarova
et al., 2003; Valyi-Nagy et al., 2002). The assembly of VLDL is
highly dependent on the availability of neural lipid in hepatocytes
and the capacity to transfer TG to premature VLDL particles. The
activity of DGAT1 (diacylglycerol O-acyltransferase 1) was
shown to influence VLDL secretion and particle size (Yamazaki
et al., 2005). As an enzyme involved in the de novo biosynthesis
of TG and phospholipids, lipin-1 could control the assembly and
secretion of hepatic VLDL by converting of phosphatidate (PA) to
diacylglycerol (DG) (Bou Khalil et al., 2008). CEs that are packed
into the VLDL core are generated by cholesterol-esterifying
enzymes ACAT1/2 (Buhman et al., 2000). Liver fatty acid-binding
protein (L-Fabp) was shown to regulate VLDL secretion, presum-
ably by controlling fatty acid uptake under fasting conditions
(Newberry et al., 2003). There was also an inverse relationship
between the size of apoB and the density of VLDL analog
formed, i.e., the C-terminal truncation of apoB-100 could
form higher-density lipoproteins, although apoB-48 can also
assemble lipid-enriched VLDL (Stillemark-Billton et al., 2005),
suggesting that the C terminus of apoB-100 or apoB-48 plays
an important role in promoting VLDL lipidation. It was reported
that apoB secretory control via post-ER presecretory proteolysis
and autophagosomes was a key component of normal and path-
ologic regulation of plasma apoB levels (Pan et al., 2008).
Cide (cell death-inducing DFF45-like effector) proteins,
including Cidea, Cideb, and Fsp27 (Cidec in human), were orig-
inally identified by their sequence homology to the N-terminal
region of DNA fragmentation factor DFF40/45 (Inohara et al.,
1998). While Cidea is expressed at high levels in brown adiposel Metabolism 9, 177–190, February 4, 2009 ª2009 Elsevier Inc. 177
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Cideb in VLDL Lipidation and MaturationFigure 1. Cideb/ Mice Show Hypolipidemia and TG Accumulation in Liver under Fasting Condition
(A) Levels of plasma TG in wild-type (+/+) andCideb/ (/) mice under fed (n = 9 and 11, respectively) and 16 hr fasting (n = 19 and 12, respectively) conditions.
Cideb/ mice show hypolipidemia after 16 hr fasting. ***p < 0.001. Error bars are ± SEM.178 Cell Metabolism 9, 177–190, February 4, 2009 ª2009 Elsevier Inc.
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Cideb in VLDL Lipidation and Maturationtissue (BAT), Cideb mRNAs and proteins are also detected in
various tissues with the highest levels of expression in the liver,
moderate levels in kidney, and lower levels in stomach and small
intestine. When overexpressed, Cideb proteins can form a homo-
dimer that is mediated by their C-terminal regions (Chen et al.,
2000) and induce caspase-independent cell death. We observed
that mice deficient in Cidea or Cideb exhibit high energy expen-
diture and are resistant to high-fat diet-induced obesity and dia-
betes (Li et al., 2007; Zhou et al., 2003). However, mechanisms
by which Cideb regulates lipid homeostasis in the liver remain
unknown. We report here that Cideb, a smooth ER- and LD-
associated protein, plays an important role in the VLDL lipidation
and maturation by interacting with apoB-100/-48 and transfer-
ring TG in LDs to higher-density VLDL precursor.
RESULTS
Increased TG Accumulation and Reduced VLDL-TG
Secretion in Livers of Cideb/ Mice
We previously observed that Cideb/ mice have increased
whole-body metabolic rate and are resistant to diet-induced
obesity. To define the mechanism responsible for such a pheno-
type, we measured plasma TG levels and observed that they
were similar between wild-type and Cideb/ mice under fed
condition. However, plasma TG levels in Cideb/ mice were
approximately 50% lower than that in wild-type mice after
16 hr fasting (0.52 ± 0.06 versus 1.07 ± 0.12 mg/ml, p < 0.01) (Fig-
ure 1A). Consistent with reduced plasma TG, levels of apoB-
100/-48 in plasma were also significantly decreased in Cideb/
mice under fasting condition (Figure 1B). The reduction in
plasma levels of apoB was not due to reduced gene expression,
as levels of apoB proteins and mRNA in the liver were similar
between wild-type and Cideb/ mice under either fed or fasting
conditions (Figure 1C and Figure S1). On the contrary, levels of
hepatic TG in Cideb/ mice were significantly higher than that
in wild-type mice under fasting condition, as evidenced by oil
red O staining (Figure 1D) and mass determination (Figure 1E)
(approximately 40% higher, p < 0.05). Likewise, levels of free
fatty acids (FFAs) (1.69 ± 0.13 versus 4.62 ± 0.83 mg/g protein,
p < 0.01) and CEs (117.2 ± 10.5 versus 195.2 ± 27.2 mg/g
protein, p < 0.01) in the liver were also significantly increased
under fasting condition in Cideb/ mice (Figures 1F and 1G),
while levels of free cholesterol in the liver of wild-type and
Cideb/ mice appeared to be similar (Figure S2). Subcellular
fractionation experiments showed that the increased TG in
Cideb/ liver was mainly associated with cytosol (Figure 1H),
as the cytosolic TG in Cideb/ liver was approximately 4-fold
higher than that in wild-type liver (235.19 ± 41.09 versus
64.03 ± 17.01 mg/g protein, p < 0.01). Levels of TG associated
with microsomes were similar between the two groups of mice
(119.54 ± 7.56 versus 112.00 ± 10.80 mg/g protein). TheseCedata suggest that Cideb/ mice have reduced levels of plasma
TG and increased TG accumulation in the liver under fasting
condition.
To determine whether accumulation of hepatic TG in Cideb/
mice was the result of increased TG synthesis or reduced VLDL
secretion, we measured the in vivo rate of TG secretion in mice
fasted for 8 hr by injecting intravenously with Triton WR-1339,
which could block VLDL catabolism by impeding the action of
lipoprotein lipase (LPL), hepatic lipase (HL), endothelial lipase
(EL), and VLDL clearance (Borensztajn et al., 1976). Under this
condition, levels of plasma TG are mainly derived from hepatic
VLDL secretion. Levels of plasma TG in Cideb/ mice injected
with Triton WR-1339 were approximately 70% lower than those
in wild-type mice at all time points tested (Figure 2A [top panel],
p < 0.001), indicative of reduced hepatic VLDL-TG secretion.
Consistent with reduced plasma TG levels, the color of plasma
collected from Cideb/ mice appeared to be transparent and
bright, while plasma from wild-type mice is pale and turbid (Fig-
ure 2A [lower panel]).
Interestingly, the secretion rates of apoB-100 and apoB-48 in
the presence of Triton WR-1339 were similar between wild-type
and Cideb/ mice (Figure 2B). Fractionation of plasma lipopro-
teins into VLDL, LDL, and HDL by gel filtration revealed drasti-
cally lower levels of apoB-100/-48 and TG in VLDL fractions of
Cideb/ mice (Figure 2C). Levels of cholesterol in VLDL and
HDL were also decreased in Cideb/ mice (Figure 2C [bottom
panel]). Electron microscopic analysis of VLDL particles showed
that the size of VLDL from Cideb/ mice was significantly
smaller than that from wild-type mice (Figure 2D). The diameter
of VLDL particles isolated from Cideb/ mice was only 28.3 ±
10.0 nm, whereas the diameter of VLDL particles from wild-type
mice was 45.3 ± 17.5 nm. These data suggest that Cideb
deficiency results in decreased rate of hepatic VLDL-TG secre-
tion and diminished VLDL particle size. As we observed no
difference in apoB-100/-48 secretion between wild-type and
Cideb/ mice, the reduced TG secretion might be due to the
defect in VLDL lipidation in Cideb/ liver. Furthermore,
reduced plasma levels of apoB-100/-48 are likely due to
an increased clearance of VLDL particles in Cideb/ mice.
The reduced hepatic secretion of VLDL-TG but not VLDL-
apoB in Cideb/ mice was determined further using isolated
primary hepatocytes. The hepatocytes were cultured in the
presence of oleic acids (OAs) to stimulate TG synthesis.
Compared with that from wild-type hepatocytes, secretion of
TG associated with VLDL from Cideb/ hepatocytes was
significantly lower (Figure 3A). Considering that there was
a 1.4-fold increase in TG mass in Cideb/ hepatocytes, we
normalized the amount of radiolabeled palmitate secreted from
Cideb/ hepatocytes by multiplying by a factor of 1.4. We also
observed significantly reduced TG secretion inCideb/ hepato-
cytes (Figure S3).(B) Levels of plasma apoB-100/-48 in wild-type (+/+) and Cideb/ (/) mice after 16 hr fasting (lower panel). Albumin stained with Coomassie Brilliant Blue
G-250 was used as a loading control. Top panel shows the semiquantitative analysis of apoB-100/-48. Error bars are ± SEM.
(C) Liver apoB-100/-48 levels in wild-type (+/+) and Cideb/ (/) mice under fed and fasting conditions.
(D) Representative photomicrographs of liver sections stained with oil red O after 16 hr fasting. Scale bars, 100 mm.
(E–G) Increased levels of hepatic TG, FFAs, and CE in the livers of wild-type (+/+) and Cideb/ (/) mice under fed and 16 hr fasting conditions (n = 6 for each
genotype). *p < 0.05; **p < 0.01. Error bars are ± SEM.
(H) TG levels in cytosolic and microsomal fractions (n = 5) from the livers of wild-type (+/+) and Cideb/ mice (/). Error bars are ± SEM.ll Metabolism 9, 177–190, February 4, 2009 ª2009 Elsevier Inc. 179
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Cideb in VLDL Lipidation and MaturationFigure 2. Decreased VLDL-TG Secretion and Reduced VLDL Size in Cideb/ Mice
(A) Decreased VLDL-TG secretion in Cideb/ mice. Cideb/ (/, n = 7) and wild-type (+/+, n = 6) mice were injected with 500 mg/kg body weight of Triton
WR-1339 after 8 hr fasting. Blood samples were collected at the indicated durations after Triton WR-1339 injection. Error bars represent SD ***p < 0.001. Lower
panel represents the photograph image of plasma samples from wild-type (+/+) and Cideb/ (/) mice treated with Triton WR-1339 for 4 hr.
(B) The rate of apoB-100/-48 secretion was similar between wild-type and Cideb/ mice. Mice were injected with Triton WR-1339 after 8 hr fasting, and blood
was collected at indicated durations. Levels of plasma apoB-100/-48 in wild-type (+/+) and Cideb/ (/) were detected by immunoblotting (upper panel). The
apoB-100/-48 levels were semiquantified using Bio-Rad Quantity One software (lower panel).
(C) Plasma lipoprotein profile analysis. VLDL (fraction 15–17), LDL (fraction 18–26), and HDL (fraction 27–35) from 300 ml plasma of wild-type (filled circles) and
Cideb/ (open circles) mice fasted for 8 hr were used for analysis.
(D) Reduced VLDL size in Cideb/ mice. Wild-type (+/+) and Cideb/ (/) mice fasted for 8 hr were treated with Triton WR-1339 for 4 hr. The isolated VLDL
particles were visualized by electron microscopy. The diameters of VLDL particles were measured and analyzed using Image-Pro Plus 5.0. Scale bars, 100 nm.The reduced TG secretion was not due to reduced TG
synthesis, as the rate of TG incorporation in Cideb/ hepato-
cytes appears to be similar (Figure 3B), or slightly higher, if calcu-
lated by the specific activity of FFAs, as Cideb/ hepatocytes
contain higher amount of intracellular FFA. The rate of fatty
acid uptake and the enzymatic activity of DGAT and GPAT
were also similar between wild-type and Cideb/ hepatocytes
(data not shown). Furthermore, the reduced TG secretion was180 Cell Metabolism 9, 177–190, February 4, 2009 ª2009 Elsevier Inc.
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Cideb in VLDL Lipidation and MaturationFigure 3. Reduced TG but Not ApoB-100/-48 in VLDL Particles Secreted from Cideb/ Primary Hepatocytes
(A) Reduced TG secretion in Cideb/ hepatocytes. Wild-type (filled circles) and Cideb/ (open circles) hepatocytes were cultured in 100 mM palmitate contain-
ing tracer of [9,10-3H]palmitate (2 mCi/well) for 2 hr. Levels of radiolabeled TG in media were determined at the indicated duration (n = 6). **p < 0.01 and ***p <
0.001. Error bars are ± SEM.
(B) The rate of TG synthesis in hepatocytes. Wild-type (+/+) and Cideb/ (/) hepatocytes (n = 6) were incubated with radiolabeled [9,10-3H]palmitate for 2 hr.
TG in hepatocytes was extracted and evaluated by TLC. Error bars are ± SEM.
(C) Similar levels of apoB-100/-48 in VLDL particles secreted from wild-type and Cideb/ hepatocytes. Primary hepatocytes from wild-type and Cideb/ mice
(n = 4) were incubated with [35S]methionine/cysteine for 1 hr, and apoB-100/-48 immunoprecipitated in the medium were separated by SDS-PAGE and exposed
to X-ray film. Error bars are ± SEM.
(D–F) Cytosolic levels of TG (D), apoB protein (E), and apoB mRNA (F) in primary hepatocytes (n = 5) of wild-type andCideb/ mice in the presence or absence of
100 mM OAs for indicated duration. *p < 0.05: **p < 0.01. Error bars in (D) and (F) are ± SEM.not due to lower levels of MTP, as levels of protein and mRNA for
MTP were similar between wild-type and Cideb/ mice under
either fed or fasting conditions (Figures S4A and S4B). The
amount of apoB-100/-48 secreted as VLDL particles was deter-
mined by pulse-chase experiments. Levels of apoB-100/-48
secreted from two groups of hepatocytes were similar
(Figure 3C). These data suggest that Cideb/ hepatocytes
secrete the same number of VLDL particles that contain less
TG, which is probably attributable to impaired TG utilization
during VLDL maturation. Consistent with increased TG accumu-
lation in the livers of Cideb/ mice, levels of TG in Cideb/
hepatocytes were also significantly higher in either the presence
(1954.83 ± 133.75 versus 1450.25 ± 50.75 mg/g protein, p < 0.01)
or absence (1143.41 ± 89.08 versus 767.70 ± 142.80 mg/gCell Metabolism 9, 177–190, February 4, 2009 ª2009 Elsevier Inc. 181
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Cideb in VLDL Lipidation and MaturationFigure 4. Cideb Is Localized to LDs and Smooth ER
(A) Cideb is enriched in liver microsomal and LD fractions. b-tubulin, a cytosol marker; calnexin, an ER marker; Cox IV, a mitochondria marker; GS28, a Golgi
marker; and ADRP, an LD marker. Twenty micrograms of total liver lysate and five micrograms of each fraction were loaded for immunoblotting analysis.
(B) Cideb is enriched in smooth ER fraction. ER-I and ER-II represent rough-ER- or smooth-ER-enriched fractions respectively. Ribosomal RNA was used as
a marker for rough ER.
(C) Cideb is localized to LD. GFP-ADRP or GFP-TIP47 was cotransfected with HA-Cideb intoCideb/ hepatocytes grown in medium supplemented with 100 mM
OA overnight to enhance the formation of large LDs. Cideb proteins (red) were localized on the surface of LDs (stained with Bodipy 493/503, green; upper panel).
The subcellular localization of Cideb (red) was overlapping with that of GFP-ADRP (green; middle panel) and GFP-TIP47 (green; lower panel).
(D) Cideb proteins are localized on ER network. HA-Cideb and GFP-CB5 (Cytochrome B5) were cotransfected into Cideb/ hepatocytes. Cideb (red) formed
a granular structure along ER network, overlapping with ER-specific protein CB5 in hepatocytes cultured without OA.
(E) Cideb (red) is colocalized with smooth ER protein DGAT2 (Myc-DGAT2; green) in the Cideb/ hepatocytes cultured in the absence of OA. Scale bars, 5 mm.protein, p < 0.05) of OA (Figure 3D). Consistent with results from
liver tissue, levels of apoB protein and mRNA in isolated primary
hepatocytes were similar between wild-type andCideb/ hepa-
tocytes in the presence or absence of OA (Figures 3E and 3F).
Overall, data from animals and isolated primary hepatocytes
suggest that VLDL lipidation process is defective in the absence
of Cideb.
Cideb Is Localized to ER and LDs
Recruitment of TG during maturation of VLDL takes place in the
ER/Golgi secretory compartments. To provide further insight into
Cideb-regulated VLDL lipidation, we determined the subcellular
localization of Cideb by biochemical subcellular fractionation
and western blot analysis (Figure 4A). The majority of Cideb
protein was cofractionated with adipocyte differentiation-related182 Cell Metabolism 9, 177–190, February 4, 2009 ª2009 Elsevier Inc.
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Cideb in VLDL Lipidation and Maturationprotein (ADRP), an LD-specific marker. Cideb was also detected
in microsomes (mainly ER) and Golgi-enriched fractions, but was
absent in cytosolic or mitochondrial fractions. The purity of each
fraction was evaluated by using organelle-specific markers.
b-tubulin, a cytosolic protein, was only detected in cytosolic
fraction. Cox IV, a mitochondria-specific protein, was detected
at high levels in mitochondria. Furthermore, GS28, a trans-Golgi
specific marker, was detected only in the Golgi fraction. A small
amount of Cox IV and calnexin was detected in the Golgi frac-
tion, suggesting that the Golgi fraction may contain a low amount
of ER and mitochondria. When the microsomal fraction was
further separated into rough ER-enriched fraction (ER-I) and
smooth ER-enriched fraction (ER-II) by discontinued sucrose
gradient centrifugation (Croze and Morre, 1984), Cideb was
predominantly detected in ER-II (Figure 4B). Localization of
Cideb in LDs was confirmed by reintroducing HA-tagged Cideb
into Cideb/ hepatocytes cultured in the presence of OA to
promote TG synthesis and induce formation of large LDs. Visual-
ization of Cideb with HA antibody showed ring-like structures
at the periphery of LDs (visualized by Bodipy 493/503) (Figure 4C
[top panels]). Additional experiments showed that Cideb
was completely colocalized with ADRP or TIP47 (tail interacting
protein of 47 kDa), two well-characterized LD-associated
proteins (Figure 4C [middle and bottom panels]). These data
strongly suggest that Cideb is a LD-associated protein, the
same localization as Cidea and Fsp27 that share high sequence
homology with Cideb (Keller et al., 2008; Puri et al., 2008; Toh
et al., 2008).
The subcellular localization of Cideb on ER was further
confirmed by overexpression of HA-tagged Cideb with ER-
specific marker GFP-CB5 (cytochrome B5) in Cideb/ hepato-
cytes (Figure 4D). Cideb proteins showed typical ER pattern, with
intensive staining on perinuclear regions. Subcellular localization
of HA-tagged Cideb formed intensive granular structures along
GFP-CB5 network, and similar colocalization of Cideb on ER
structure was found when it was overexpressed in COS-7 cells
(Figure S5A). This granular staining of Cideb overlapped very
well with the smooth ER-localized DGAT2 in Cideb/ hepato-
cytes (Figure 4E) and COS-7 cells (Figure S5B). However, no co-
localization of Cideb with MitoTracker was observed in COS-7
cells or hepatocytes (Figure S5C). These data suggest that Cideb
proteins are predominantly located on LDs and smooth ER
where enzymes involved in synthesis of TG, phospholipids,
and steroids are localized and VLDL assembly takes place.
Identification of the LD and ER Association
Domain of Cideb
To determine whether Cideb is an integral or peripheral protein of
the ER membranes, the isolated microsomal fraction was treated
separately with high salt, denaturants (urea and Na2CO3, pH 11),
and detergents such as deoxycholate (DOC) and SDS. Cideb
protein was not removed from the surfaces of microsome
when treated with high salt, high pH, or 2.5 M urea. Only in the
presence of strong detergents such as 1% DOC or SDS could
Cideb protein be dissociated from the ER membrane (Figure 5A).
The solubility of Cideb is similar to that of calnexin, an ER
membrane-integrating protein, suggesting that Cideb is tightly
associated with the ER membrane as an integral membrane
protein. Similarly, only DOC or SDS could dissociate CidebCefrom isolated LD fractions (Figure S5D). These data suggest
that Cideb is integrated into the ER membranes and LDs.
The topology of Cideb with respect to ER membrane, particu-
larly the orientation of its N terminus and C terminus on the cyto-
solic or luminal side of the ER, was determined by trypsinization
of isolated microsomal fractions from mouse livers. Cideb and its
proteolytic products were detected by western blot analysis
using the antibody against an epitope at the N-terminal region
(aa 1–117) of Cideb. As shown in Figure 5B, Cideb proteins grad-
ually disappeared as the amounts of trypsin increased. Calnexin,
an integral ER protein known to have its C terminus exposed to
the cytosolic side, similarly disappeared upon trypsin digestion.
On the contrary, glucose-regulated protein 94 (GRP94), a protein
localized to ER lumen, was protected for trypsin digestion,
unless the integrity of microsomes was destroyed by 1% Triton
X-100. Similar experiments using Cideb C-terminally tagged
to the Myc epitope also showed that the C terminus of Cideb
is localized on the cytosolic side of ER membrane, as Cideb-
Myc was not protected for trypsin digestion (Figure S5E). These
data indicate that both N terminus and C terminus of Cideb are
oriented toward the cytosolic side.
To characterize further the LD and ER membrane-localization
signal(s) within Cideb, we performed secondary structure anal-
ysis for hydrophobicity and composition of a helices. Cideb is
relatively hydrophilic, with a predicted isoelectric point of 9.01.
One prominent hydrophobic region is located at the C-terminal
region between aa 166 and aa 195 (Figure 5C [upper panel]),
which forms two potential a helices (Figure 5C [lower panel]). A
series of HA-tagged truncations of Cideb were generated and
transfected into HepG2 cells to determine their subcellular local-
ization (Figure 5D). Truncated proteins that contained aa 1–117
or aa 1–166 showed diffused staining patterns, while those
containing aa 118–219, aa 166–219, or aa 1–195 formed a ring
structure around LDs. The Cideb protein with deletion of aa
166–195 had a diffused staining pattern and did not colocalize
with LDs or ER. These data suggest that the LD and ER targeting
signal is encoded by aa 166–195. To confirm this, we generated
a fusion protein in which aa 166–195 of Cideb was linked to GFP
(GFP-Cideb166–195). The resulting fusion protein was localized
to LDs (Figure 5E) or localized to the ER network when cells were
not incubated with OA to form large LD (data not shown).
Cideb Interacts with ApoB
To gain an insight into molecular mechanism by which Cideb
regulates TG recruitment during VLDL maturation, we searched
for Cideb-interacting proteins via a yeast two-hybrid screen.
Screening of 2.6 million cDNAs from a liver library yielded
99 positive clones that showed specific interaction with Cideb,
of which 18 contained the C-terminal region (aa 4306–4536) of
apoB (apoB-100C). We generated a series of truncated Cideb
proteins and tested the interaction between Cideb and apoB-
100C (summarized in Figure S6A). Full-length Cideb (aa 1–219)
and truncations that contained aa 1–180 and aa 1–166, respec-
tively, pulled down apoB-100C, whereas those containing aa 1–
117 or aa 166–219 did not. These results suggest that the region
mediating the interaction between Cideb and apoB-100C was
localized between aa 118 and aa 165 of Cideb. Indeed, deletion
of aa 118–165 (D118–165) within Cideb abolished its interaction
with apoB-100C. Cideb lacking the membrane-targeting domainll Metabolism 9, 177–190, February 4, 2009 ª2009 Elsevier Inc. 183
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Cideb in VLDL Lipidation and MaturationFigure 5. Identification of Membrane-Targeting Domain on Cideb
(A) Cideb is tightly associated with ER membrane. Microsome fraction from mouse liver was treated with salt (1 M KCl), high pH solution (0.1 M Na2CO3, pH 11),
denaturants (2.5 M urea), and detergents (1% Triton and 1% SDS). Cideb and calnexin in pellets (P) and supernatants (S) were detected by immunoblotting
analysis.
(B) N terminus of Cideb is localized on the cytosolic side of ER membrane. One half milligram microsomal fractions isolated from mouse liver was resuspended in
one hundred microliters of Buffer A in the absence (left) or presence (right) of 1% Triton X-100. Fractions were treated with increasing amounts of trypsin for 30 min
and subjected to immunoblotting analysis with anti-Cideb N-terminal (aa 1–117) antibody or anti-calnexin C-terminal antibodies. GRP94, a protein localized to the
ER lumen, was used to indicate the integrality of microsomes.
(C) Hydropathy, a-helical properties, and the schematic diagram of Cideb and its truncations. The hydropathy profiles of Cideb were analyzed as previously
described (Roseman, 1988) (upper panel). The arrows indicate the hydrophobic (aa 190) and hydrophilic (aa 178) sites of Cideb between aa 166 and aa 195.
The a helices of Cideb were predicted by Chou-Fasman analysis (Chou and Fasman, 1978). The relationship of the fragments to the predicted a-helical properties
of Cideb is indicated by the bars below the Chou-Fasman profile. The arrows indicate the position of the a-helical region. The localization of Cideb truncations on
LDs were summarized in the lower panel.184 Cell Metabolism 9, 177–190, February 4, 2009 ª2009 Elsevier Inc.
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Cideb in VLDL Lipidation and Maturation(D166–195) could coimmunoprecipitate with apoB-100C, sug-
gesting that the membrane localization domain is not required
(Figure 6A). The interactions between apoB-100C and various
Cideb truncations were also tested in yeast two-hybrid assay
and were consistent with the result of coimmunoprecipitation
(Figures S6B and S6C). These data suggest that Cideb interacts
specifically with the C-terminal region of apoB-100 (apoB-100C),
and that aa 118–165 of Cideb mediates the interaction between
Cideb and apoB-100C. The Cideb/apoB interaction in vivo
was further confirmed by coimmunoprecipitation experiments.
Immunoprecipitation of apoB from liver microsomal fractions
using anti-apoB antibodies (but not control preimmune serum)
pulled down Cideb (Figure 6B), suggesting that Cideb forms
a specific complex with apoB in vivo. We then tested whether
aa 118–165 of Cideb mediates its interaction with apoB in vivo
by infecting Cideb/ hepatocytes with adenovirus encoding
HA-tagged full-length and truncated forms of Cideb. Endoge-
nous apoB proteins were immunoprecipitated with antibodies
against apoB. Cideb proteins with deletion of 118–165 (D118–
165) were not detected in the precipitated complex (Figure 6C).
These data suggest that aa 118–165 of Cideb mediates its inter-
action with apoB in vivo.
To further evaluate the interaction of Cideb and apoB, HA-
tagged Cideb was coexpressed with apoB-100 and its various
truncations (apoB-94, apoB-72, or apoB-48) in 293T cells.
ApoB-100 and its truncations were immunoprecipitated with
anti-apoB antibody. Surprisingly, we observed that Cideb was
coimmunoprecipitated with apoB-100 and its truncations,
including apoB-94, apoB-72, and apoB-48 (Figure 6D), suggest-
ing that besides the C-terminal region of apoB-100, the
N-terminal of apoB-100 (apoB-48) also interacts with Cideb.
To determine the region(s) on Cideb that mediate its interaction
with apoB-48, HA-tagged Cideb and its truncations were co-
transfected with apoB-48 in 293T cells, and apoB-48 was immu-
noprecipitated down by anti-apoB antibody. Cideb with deletion
of aa 118–165 could not coimmunoprecipitate with apoB-48
(Figure S6D), suggesting that aa 118–165 of Cideb mediates its
interaction with both the C-terminal and N-terminal (apoB-48)
regions of apoB-100. We further evaluated the subcellular local-
ization of apoB-100 and Cideb by cotransfecting apoB-100 and
HA-tagged Cideb into Cideb/ hepatocytes. As shown in Fig-
ure 6E, the distribution of Cideb was similar to that of apoB-
100, providing a cellular basis for the interaction between apoB
and Cideb. However, Cideb/apoB interaction might be transient
and dynamic, as Cideb was not detected in secreted VLDL parti-
cles (Figure S7).
ApoB Interaction and Membrane Localization of Cideb
Are Required to Promote VLDL Lipidation
Based on localization of Cideb to LDs and smooth ER and its
interaction with apoB-100, we postulated that Cideb may play
a role in TG assembly with VLDL precursors during VLDL matu-
ration. To test this, we injected adenoviruses that express
full-length Cideb or its truncations into Cideb/ mice or infectedCeprimary hepatocytes isolated from Cideb/ mice. Expression
levels of Cideb and its various truncations were similar in the
infected hepatocytes (Figure 7A). When full-length Cideb was
expressed in Cideb/ hepatocytes, the amount of TG secreted
from Cideb/ hepatocytes was approximately 3-fold higher
than that from cells infected with control GFP adenovirus
(6508 ± 1136 versus 2853 ± 110 DPM/mg protein, p < 0.01) (Fig-
ure 7B). Expression of the N-terminal region (aa 1–117) of Cideb
(Cideb1–117) inCideb/ hepatocytes did not result in increased
TG secretion. Expression of the C-terminal region (aa 118–219)
of Cideb that contained both the apoB-100/-48 binding region
and LD localization signal resulted in small yet significant in-
crease in TG secretion (3337 ± 169 versus 2853 ± 110 DPM/mg
protein, p < 0.05), suggesting that N-terminal region is required
to restore full activity of Cideb in promoting VLDL lipidation.
More importantly, deletion of the apoB-100/-48 interaction
domain (aa 118–165) or the LD-/ER-targeting signal (aa 166–
195) within Cideb completely abolished its ability to enhance
TG secretion in isolated Cideb/ hepatocytes (Figure 7B), sug-
gesting that these two domains are important for promoting
VLDL secretion. Consistent with the result obtained in hepato-
cytes, when Cideb was expressed in the livers of Cideb/
mice, it could significantly increase TG secretion (0.88 ± 0.09
versus 0.54 ± 0.06 mg/ml, p < 0.05). Surprisingly, expression
of the C-terminal region of Cideb in Cideb/ mice could also
enhance plasma TG levels. Expression of the N-terminal region
(aa 1–117) of Cideb or its truncations that lacked the apoB inter-
action domain or LD targeting domain had no effect on TG secre-
tion (Figure 7C). Moreover, expression of full-length Cideb in the
livers of Cideb/ mice resulted in reduction of TG accumulation
(213.11 ± 44.53 versus 417.52 ± 96.45 mg/g protein, p < 0.05),
whereas the C terminus had weaker effects on TG accumulation
(302.77 ± 30.57 versus 417.52 ± 96.45 mg/g protein, p = 0.13)
(Figure 7D), and similar results were observed in Cideb/ hepa-
tocytes (Figure S8). Interestingly, we observed that Cideb
C-terminal region could increase TG secretion in vivo but not in
isolated hepatocytes. The reason behind this discrepancy is
not clear. It is possible that isolated hepatocytes could not fully
mimic in vivo conditions, and extrahepatic factors are required
for efficient VLDL-TG secretion. These data further confirm that
the interaction between Cideb and apoB-100/-48 and its locali-
zation to ER and LDs are both required for promoting the acqui-
sition of TG during VLDL maturation.
DISCUSSION
We have demonstrated that Cideb is an ER- and LD-localized
protein, and that Cideb/ mice display decreased secretion of
VLDL-TG secretion while secretion of apoB is unaltered in the
mutant mice. We also show that Cideb interacts with apoB-
100 and apoB-48, and the interaction is required for Cideb to
enhance VLDL lipidation. Although Cideb does not seem to
possess any ER retention signal, it is localized on the smooth
ER and LDs membrane in hepatocytes. Membrane anchoring(D) Mapping of the LD-targeting domain on Cideb. HepG2 cells transfected with HA-tagged Cideb truncations were grown in the medium supplemented with
100 mM OA overnight. Cells were immunostained with anti-HA antibody (red) and LDs were stained with Bodipy 493/503 (green).
(E) Amino acids 166–195 of Cideb are sufficient to target GFP to LDs. GFP-Cideb165–195 (GFP-tagged aa 165–195 of Cideb) is localized on the surface of LDs.
Scale bars, 5 mm.ll Metabolism 9, 177–190, February 4, 2009 ª2009 Elsevier Inc. 185
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Cideb in VLDL Lipidation and MaturationFigure 6. Cideb Interacts with ApoB-100 and ApoB-48
(A) Cideb interacts with the C terminus of apoB-100 (apoB-C6, aa 4306–4536), and aa 118–165 of Cideb mediates their interaction. IP, immunoprecipitation; IB,
immunoblotting.
(B) In vivo interaction between apoB and Cideb. Liver microsomal fractions were isolated, and apoB-100/-48 proteins were immunoprecipitated by anti-apoB
antibodies (anti-apoB) cross-linked to CNBr-activated Sepharose 4B beads. Cideb proteins in the immunoprecipitated products were detected with anti-Cideb
antibody.
(C) Amino acids 118–165 of Cideb mediate its interaction with apoB in hepatocytes. Cideb/ hepatocytes were isolated and infected with adenovirus (Adv)-con-
tained, HA-tagged Cideb and its truncations. ApoB proteins were immunoprecipitated with anti-apoB antibodies (IP), and the coimmunoprecipitated Cideb
proteins were detected with anti-HA antibodies (IB).186 Cell Metabolism 9, 177–190, February 4, 2009 ª2009 Elsevier Inc.
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Cideb in VLDL Lipidation and Maturationof Cideb was mediated by aa 165–195. We previously showed
that Cideb, when overexpressed in heterologous cells such as
293T and CHO cells, was overlapped with mitochondrial marker
MitoTracker (Chen et al., 2000). However, after careful evaluation
of Cideb ectopic expression in many different cell types with
(D) Both apoB-100 and apoB-48 interact with Cideb. HA-tagged Cideb and plasmid DNAs containing apoB-100, apoB-94, apoB-72, or apoB-48 were cotrans-
fected into 293T cells. ApoB proteins were immunoprecipitated by anti-apoB antibodies, and Cideb proteins in immunoprecipitated product were detected with
anti-HA antibodies.
(E) Cideb colocalized with apoB-100. Hepatocytes that were transfected with apoB-100 and HA-Cideb were grown in the medium supplemented with 100 mM OA.
Colocalization of apoB-100 (red) and Cideb (green) was observed. Scale bar, 5 mm.
Figure 7. Cideb Promotes TG Secretion in
Cideb/ Hepatocytes and Liver
(A) Expression levels of Cideb and its truncation in
Cideb/ hepatocytes that were infected with
adenovirus (MOI = 100) containing Cideb and its
truncations.
(B) TG secretion from Cideb/ hepatocytes
infected with adenovirus (Adv) containing GFP or
truncated Cideb (n = 6). **p < 0.01. Error bars are
± SEM.
(C and D) TG levels in plasma (C) and in liver (D) of
Cideb/mice infected with adenovirus containing
GFP or truncated Cideb (Adv-Cideb). Cideb/
mice were injected with 13 109 pfu/mouse adeno-
virus through tail veins, and plasma and liver TG
were determined after 6 days of infection (n = 6).
*p < 0.05, **p < 0.01. Error bars are ± SEM.
(E) Schematic illustration of the role of Cideb in
VLDL lipidation and maturation. Cideb, by local-
izing to cytosolic side of ER and the surface of
LDs, could interact with the both apoB-100 and
apoB-48 and facilitate the transfer of TG synthe-
sized on ER and in cytosolic LD to immature
VLDL particles, leading to the sufficient lipidation
and maturation of VLDL precursors. In the
absence of Cideb, TG could not be effectively
transported to VLDL precursors, resulting in ineffi-
cient VLDL lipidation and accumulation of neutral
lipid in the cytosolic fraction of hepatocytes.
extensive time courses, we observed
that the overlapping staining between Ci-
deb and mitochondrial marker was in fact
only observed at late stages of cell death
when cellular structure is disrupted by
Cideb overexpression. Endogenous Ci-
deb did not appear to be present in mito-
chondrial fractions.
Using yeast two-hybrid screening
approach, we identified apoB as one of
the 20 Cideb interacting proteins, and we
confirmed specific interaction between
Cideb and the C-terminal domain of
apoB-100 using coimmunoprecipitation
assays. Interestingly, we also observed
specific interaction between Cideb and
apoB-48. In addition, we found that the
same domain on Cideb (aa 118–165) can
confer its interaction with both apoB-48
and the C terminus of apoB-100. The
interaction between apoB-48 and Cideb suggests that Cideb
could also play a role in controlling the lipidation of apoB-48-con-
taining VLDL particles secreted in rodent liver cells. Localization
of Cideb to TG synthesis sites on smooth ER and its interaction
with apoB may help to target newly synthesized TG to prematureCell Metabolism 9, 177–190, February 4, 2009 ª2009 Elsevier Inc. 187
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Cideb in VLDL Lipidation and MaturationVLDL particles and promote their lipidation. Cideb may interact
with apoB at the process of VLDL assembling when nascent
apoB proteins are anchored on ER membrane as a membrane-
spanning protein to help recruit newly synthesized TG to prema-
ture VLDL particles. The transmembrane nature of apoB on ER
after its translation in the early stage in HepG2 cells was indeed
shown by several groups (Liang et al., 2000; Sakata et al.,
1999), although the exact region that is localized to the cytosolic
site of ER was not determined yet. More importantly, newly
synthesized apoB and TG were shown to be accumulated in
smooth ER membrane (Cartwright et al., 2000). It is likely that
Cidea could interact with apoB on smooth ER membrane and
facilitate VLDL lipidation. Future experiments will be needed to
characterize the transmembrane topology of apoB on smooth
ER. When VLDL particles are dissociated from ER membrane
and enter into ER lumen for secretion, Cideb/apoB interaction is
disrupted, and Cideb is dissociated from VLDL particles. It would
be of great interest to characterize the signal(s) or factor(s) that
control such dynamic interaction.
Localization of Cideb on LDs and smooth ER may also provide
a mechanism through which TG in cytosolic LDs could be
supplied for high-level lipidation of VLDL during fasting state. It
is possible that the localization of Cideb on ER permits cytosolic
LDs to contact ER and premature VLDL particles, so that when
lipolysis occurs in the droplet, the released FFA can be resynthe-
sized to TG or used to make CE and phospholipids in the ER
membrane. Those lipids could form an ER luminal droplet next
to apoB or move continually onto apoB, resulting in transferring
the cytosolic lipid to VLDL and promoting its lipidation to form
TG-enriched VLDL (see Model in Figure 7E). It will be interesting
to know whether other LD-associated proteins besides Cideb
could play a role in regulating VLDL lipidation and secretion.
Additionally, despite the similar rate of apoB-100 and apoB-48
secretion between wild-type and Cideb mutant hepatocytes,
we observed decreased plasma levels of apoB-100 and apoB-
48 in Cideb/ mice. It is plausible that TG-poor VLDL particles
may have high rates of clearance by other tissues in Cideb/
mice.
We have previously observed that Cideb/ mice are lean and
resistant to high-fat diet-induced obesity and liver steatosis
(Li et al., 2007). The lean phenotype and less lipid accumulation
inwhite adipose tissue ofCideb/mice may be a combinedeffect
of decreased VLDL secretion, decreased de novo fatty acid
synthesis, and increased fatty acid oxidation in Cideb/ hepa-
tocytes. We have previously observed that levels of SREBP-1c,
a major regulator of lipogenesis in liver, are decreased in
Cideb/ mice. The reduced SREBP-1c expression could result
from increased FFA levels in Cideb/ mice, as FFA was shown
to be a negative regulator of SREBP-1c (Jump et al., 2005). We
hypothesize that the increase in hepatic FFAs is due to the
reduced TG secretion and increased TG accumulation in the liver
of Cideb/ mice. It will be interesting to further evaluate the role
of Cideb in regulating hepatic fatty acid concentration and their
biological implication. The reduced liver steatosis is rather
puzzling, as we observed increased lipid accumulation in the liver
under fasting condition in Cideb/ mice. As Cideb is expressed
in intestinal epithelium cells and interacts with apoB-48, a major
component for the generation of chylomicron in the intestine, it
is possible that Cideb may control chylomicron lipidation in the188 Cell Metabolism 9, 177–190, February 4, 2009 ª2009 Elsevier Inintestine. Deficiency of Cideb in intestine may result in defective
chylomicron lipidation, less lipid accumulation, and resistance
to high-fat diet-induced liver steatosis.
Based on our observations, we propose a model to depict the
role of Cideb in the process of VLDL maturation (Figure 7E). In
this model, Cideb, which is localized to the cytosolic sides of
TG synthesis site on smooth ER and LDs, binds to the apoB in
the precursor VLDL particles and facilitates the transport of TG
synthesized in ER or in cytosolic LDs to VLDL precursors during
VLDL lipidation. In the absence of Cideb, bulk TG from LDs
cannot be transported to VLDL precursors efficiently, resulting
in the secretion of TG-poor VLDL particles into the cytosol and
hence the accumulation of TG there. The impaired VLDL-TG
secretion in liver may account for the reduced plasma TG levels
and antiobesity phenotype observed in Cideb/ mice. Our
study has thus shown that VLDL lipidation and maturation is
mediated by Cideb and suggests that Cideb could serve as an
important therapeutic target for the controlling of hyperlipidemia.
EXPERIMENTAL PROCEDURES
Detailed procedures for mice maintenance, cell culture, subcellular fraction-
ation, coimmunoprecipitation, western blot analysis, immunofluescent stain-
ing, and virus preparation are shown in the Supplemental Data.
Analysis of Liver and Plasma Lipids
The method for measuring hepatic and plasma lipid levels was essentially the
same as described by Toh et al. (2008). For lipoprotein analysis, 300 ml of
plasma was fractionated by FPLC using a Superose 6 column. TG and choles-
terol in each fraction were extracted and separated by thin layer chromatog-
raphy. The apoB-100/-48 levels were detected by western blot using anti-
mouse apoB antibody (Biodesign) and quantified by Quantity One software
(Bio-Rad).
VLDL-TG and ApoB Secretion In Vivo and in Cultured Hepatocytes
The rate of VLDL secretion was determined by blocking VLDL catabolism with
Triton WR-1339 (Borensztajn et al., 1976). Mice were injected with Triton
WR-1339 (500 mg/kg in PBS) through tail veins after 8 hr fasting. Fifty micro-
liters of blood was drawn from the retro-orbital plexus into heparinized tubes
at 1 hr intervals after injection, and TG concentrations were measured. Levels
of apoB-100 and apoB-48 were detected by immunoblotting and semiquanti-
fied with Bio-Rad Quantity One software.
For VLDL-TG and apoB secretion in cultured hepatocytes, hepatocytes
were isolated from livers of 12-week-old wild-type andCideb/mice as previ-
ously described (Klaunig et al., 1981). ApoB secretion in hepatocytes was
examined by pulse-chase analysis as previous described (Tachibana et al.,
2005). The TG synthesis and secretion rate was measured as previously
described (Koonen et al., 2007), with modification (Supplemental Data).
Analysis of Particle Size of VLDL
VLDL particles (d < 1.006) were isolated by isopycnic KBr gradient method
(Havel et al., 1955) and negatively stained with 20 g/l phosphotungstic acid
(pH 7.0) for 2 min. The specimen was viewed under a Philips CM10 electron
microscope. The mean diameters of VLDL particles were determined using
Image-Pro Plus 5.0 image analysis software.
Large-Scale Preparation of the Recombinant Adenovirus
and Infection
The recombinant adenoviruses carrying ubiquitin-C promoter-driven full-
length or fragments of Cideb were constructed using the AdEasy-1 System
(Stratagene). The adenovirus expressing GFP was used as a control. After
large-scale amplification in AD293 cells, recombinant adenoviruses were puri-
fied by CsCl density gradient ultracentrifugation, dialyzed against PBS supple-
mented with 15% glycerol, and stored at 80C. Adenoviruses were injectedc.
Cell Metabolism
Cideb in VLDL Lipidation and Maturationvia the tail veins at a dosage of 1 3 109 pfu/mouse. The plasma and liver TG
were examined 6 days after viral injection.
Data Analyses
The data shown are means ± SEM. Differences between treatment groups
were evaluated using Student’s t test.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, Supple-
mental References, and eight figures and can be found online at http://www.
cell.com/cellmetabolism/supplemental/S1550-4131(08)00420-8.
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